Stock Earnings
Truist upgrades Sangamo Therapeutics Inc (SGMO) rating to a Buy
As this happened, Truist upgraded its Sangamo Therapeutics Inc [SGMO] rating to a Buy from a a Hold in a
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.